Maria Rosaria Carratù
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maria Rosaria Carratù has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Anna Signorile
Department of Basic Medical Sciences, Neurosciences and Sense Organs University of Bari Aldo Moro Policlinico Piazza Giulio Cesare 11 Bari Italy
1 shared publicationC. Nacci
Aldo Moro Univ Bari, Dept Biomed Sci & Human Oncol, Piazza Giulio Cesare 11, I-70124 Bari, Italy
1 shared publicationCarmela Nacci
Department of Biomedical Sciences and Human Oncology University of Bari Aldo Moro Policlinico Piazza Giulio Cesare 11 Bari Italy
1 shared publication- Concetta Altamura
Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, Bari, Apulia, Italy
1 shared publication Domenico De Rasmo
Institute of Biomembranes Bioenergetics and Molecular Biotechnology National Research Council (CNR) Bari Italy
1 shared publication- Jean-François Desaphy
Section of Pharmacology, Department of Precision and Regenerative Medicine and Ionian Area School of Medicine, University of Bari Aldo Moro Bari Italy
1 shared publication
Latest Publications
- Open Access
Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
Ovarian cancer (OC) is the deadliest gynecologic cancer, due to late diagnosis, development of platinum resistance, and inadequate alternative therapy. It has been demonstrated that membrane ion channels play important roles in cancer processes, including cell proliferation, apoptosis, motility, and invasion. Here, we review the contribution of ion channels in the development and progression of OC, evaluating their potential in clinical management. Increased expression of voltage-gated and epithelial sodium channels has been detected in OC cells and tissues and shown to be involved in cancer proliferation and invasion. Potassium and calcium channels have been found to play a critical role in the control of cell cycle and in the resistance to apoptosis, promoting tumor growth and recurrence. Overexpression of chloride and transient receptor potential channels was found both in vitro and in vivo, supporting their contribution to OC. Furthermore, ion channels have been shown to influence the sensitivity of OC cells to neoplastic drugs, suggesting a critical role in chemotherapy resistance. The study of ion channels expression and function in OC can improve our understanding of pathophysiology and pave the way for identifying ion channels as potential targets for tumor diagnosis and treatment.
Open AccessEmerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
Ovarian cancer (OC) is the deadliest gynecologic cancer, due to late diagnosis, development of platinum resistance, and inadequate alternative therapy. It has been demonstrated that membrane ion channels play important roles in cancer processes, including cell proliferation, apoptosis, motility, and invasion. Here, we review the contribution of ion channels in the development and progression of OC, evaluating their potential in clinical management. Increased expression of voltage-gated and epithelial sodium channels has been detected in OC cells and tissues and shown to be involved in cancer proliferation and invasion. Potassium and calcium channels have been found to play a critical role in the control of cell cycle and in the resistance to apoptosis, promoting tumor growth and recurrence. Overexpression of chloride and transient receptor potential channels was found both in vitro and in vivo, supporting their contribution to OC. Furthermore, ion channels have been shown to influence the sensitivity of OC cells to neoplastic drugs, suggesting a critical role in chemotherapy resistance. The study of ion channels expression and function in OC can improve our understanding of pathophysiology and pave the way for identifying ion channels as potential targets for tumor diagnosis and treatment.
- 1 January 2020
- Published by Clarivate Analytics (US) LLC in Drugs of the Future
- Vol. 45 (2) , 109-117
Alzheimer's disease murine models: focus on late-onset disease
- 1 January 2020
- Published by Clarivate Analytics (US) LLC in Drugs of the Future
- Vol. 45 (2) , 109-117
Alzheimer's disease murine models: focus on late-onset disease
- Open Access
- 16 September 2019
- Published by Madridge Publishers, LLC in Madridge Journal of Oncogenesis
- Vol. 3 (1) , 65-72
Immune Checkpoint Inhibitors: A Step forward in Cancer Management
Madridge Journal of Oncogenesis(MJO)
- 16 September 2019
- Published by Madridge Publishers, LLC in Madridge Journal of Oncogenesis
- Vol. 3 (1) , 65-72
Open AccessImmune Checkpoint Inhibitors: A Step forward in Cancer Management
Madridge Journal of Oncogenesis(MJO)
- Open Access
- 22 February 2017
- Published by Juniper Publishers in Journal of pharmacology & clinical research
- Vol. 2 (2)
Lazaroids and Neuroprotection: What Benefit?
- 22 February 2017
- Published by Juniper Publishers in Journal of pharmacology & clinical research
- Vol. 2 (2)
Open AccessLazaroids and Neuroprotection: What Benefit?
- Open Access
- 17 November 2015
- Published by Juniper Publishers in Open Access Journal of Toxicology
- Vol. 1 (1)
Methyl Mercury Injury to CNS: Mitochondria at the Core of the Matter?
- 17 November 2015
- Published by Juniper Publishers in Open Access Journal of Toxicology
- Vol. 1 (1)
Open AccessMethyl Mercury Injury to CNS: Mitochondria at the Core of the Matter?
- 1 January 2014
- Vol. 18 (1) , 28-33
Rat embryo exposure to all-trans retinoic acid results in long-term cognitive deficits.
The present study examines in particular associative learning and aversive memory abilities in adult Sprague Dawley rats exposed to all-trans retinoic acid (ATRA) in the period spanning gestational days (GD) 11-13. The ATRA dosage of 2.5 mg/kg compatible with high neonatal survival, sufficient to supply offspring for later behavioral testing, was used. The results show that the GD 11-13 ATRA exposure compromises the ability of rats to learn an active avoidance task. Indeed, unlike control rats, the ATRA-treated rats did not improve in performance over blocks of training, the number of attempts they made to avoid foot shock being significantly affected. The memory ability, assessed with the passive avoidance paradigm, was not affected by ATRA exposure. The results provide further evidence that, beyond gross CNS malformations, gestational ATRA exposure induces long-term cognitive deficits in the offspring, thus raising further warning for better control of retinoid safety during pregnancy, an aspect relevant to human health protection within the regulatory environment.
- 1 January 2014
- Vol. 18 (1) , 28-33
Rat embryo exposure to all-trans retinoic acid results in long-term cognitive deficits.
The present study examines in particular associative learning and aversive memory abilities in adult Sprague Dawley rats exposed to all-trans retinoic acid (ATRA) in the period spanning gestational days (GD) 11-13. The ATRA dosage of 2.5 mg/kg compatible with high neonatal survival, sufficient to supply offspring for later behavioral testing, was used. The results show that the GD 11-13 ATRA exposure compromises the ability of rats to learn an active avoidance task. Indeed, unlike control rats, the ATRA-treated rats did not improve in performance over blocks of training, the number of attempts they made to avoid foot shock being significantly affected. The memory ability, assessed with the passive avoidance paradigm, was not affected by ATRA exposure. The results provide further evidence that, beyond gross CNS malformations, gestational ATRA exposure induces long-term cognitive deficits in the offspring, thus raising further warning for better control of retinoid safety during pregnancy, an aspect relevant to human health protection within the regulatory environment.